Novo Solutions Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Novo Solutions's estimated annual revenue is currently $1M per year.(i)
  • Novo Solutions's estimated revenue per employee is $87,000

Employee Data

  • Novo Solutions has 12 Employees.(i)

Novo Solutions's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Head DeveloperReveal Email/Phone
3
Accounting ManagerReveal Email/Phone
4
Sales and Marketing CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$338.5M86155%$484M$6.1B
#2
$1250M6469-1%$85.5M$12.2B
#3
$36.2M232-6%$28MN/A
#4
$8.4M69-8%$34.6MN/A
#5
$15.5M11154%N/AN/A
#6
N/A19N/AN/AN/A
#7
$192.3M9817%N/AN/A
#8
$4.4M38N/AN/AN/A
#9
$29.8M198136%$234M$1B
#10
$0.5M11N/AN/AN/A
#11
$42.9M28518%$45MN/A
#12
$221.8M1108-7%$74.6MN/A
#13
$5.6M48N/AN/AN/A
#14
$0.3M4N/AN/AN/A
#15
$271.2M1336N/AN/AN/A
#16
$13.9M96N/AN/AN/A
#17
$2.8M28N/AN/AN/A
#18
$0.3M4N/AN/AN/A
#19
$18.6M128N/AN/AN/A
#20
$0.9M10N/AN/AN/A
Add Company

What Is Novo Solutions?

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Novo Solutions News

2022-04-19 - CareDx Showcases Leadership with Over 25 Oral Presentations and Posters at the International Society for Heart and Lung Transplantation Meeting

Data Highlights Clinical Utility of CareDx Solutions, ... for assessing the risk of rejection and de novo donor-specific antibodies (dnDSA).

2022-04-17 - Latina-founded Banking-as-a-Service Provider NovoPayment ...

MIAMI, April 19, 2022 /PRNewswire/ -- NovoPayment announced it has secured $19 million in Series A financing, led by Fuel Venture Capital and...

2022-03-30 - Novo Integrated Sciences Signs Memorandum of ...

Boditech offers highly reliable in-vitro diagnostic solutions that empower clinicians and patients to improve health through quick and reliable...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M120%N/A
#2
$1M1233%N/A
#3
$1.2M1427%N/A
#4
N/A1417%N/A
#5
$2.3M150%N/A